Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 23 of 23 entries
View as:

Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT00731445 Org: User:
Start: 07/31/08 End: 06/30/12 Due: 06/30/13

Trial to Optimally Show the Pharmacological Action of Z-100

Phase: N/A Priority: Normal
NCT ID: NCT03476018 Org: User:
Start: 04/02/18 End: 12/10/21 Due: 12/10/22

Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02828319 Org: User:
Start: 07/31/16 End: 12/31/17 Due: 12/31/18

The Effect of Z-338 in Subjects With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00458328 Org: User:
Start: 04/30/07 End: 07/31/10 Due: 07/31/11

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02247232 Org: User:
Start: 12/31/14 End: 02/25/22 Due: 02/25/23

Exploratory Study of ZG-801 for the Treatment of Hyperkalemia

Phase: N/A Priority: Normal
NCT ID: NCT03799926 Org: User:
Start: 02/18/19 End: 02/02/21 Due: 02/02/22

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00333372 Org: User:
Start: 04/30/06 End: - Due: -

A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT04526119 Org: User:
Start: 02/22/21 End: 06/30/26 Due: 06/30/27

To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00761358 Org: User:
Start: 09/30/08 End: 08/31/10 Due: 08/31/11

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00016692 Org: User:
Start: - End: - Due: -

Phase III, Long-term, Open-label Safety Study of Z-338

Phase: N/A Priority: Normal
NCT ID: NCT01973790 Org: User:
Start: 03/31/14 End: 04/30/17 Due: 04/30/18

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00323817 Org: User:
Start: 04/30/06 End: 10/31/09 Due: 10/31/10

Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02117258 Org: User:
Start: 04/30/14 End: 03/31/17 Due: 03/31/18

Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00288925 Org: User:
Start: 09/30/05 End: - Due: -

Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02170311 Org: User:
Start: 06/30/14 End: 03/31/15 Due: 03/31/16

Mass Balance and Metabolism Study of 14C-Z-215

Phase: N/A Priority: Normal
NCT ID: NCT02618629 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17

Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02731534 Org: User:
Start: 05/31/16 End: 01/31/18 Due: 01/31/19

A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

Phase: N/A Priority: Normal
NCT ID: NCT04955678 Org: User:
Start: 08/03/21 End: 03/13/23 Due: 03/13/24

Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Phase: N/A Priority: Normal
NCT ID: NCT01237288 Org: User:
Start: 09/30/10 End: 07/31/13 Due: 07/31/14

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT00298194 Org: User:
Start: 02/28/06 End: - Due: -

A Healthy Subject Study With Z-360 and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01776463 Org: User:
Start: 01/31/13 End: 07/31/13 Due: 07/31/14

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT02463643 Org: User:
Start: 05/31/15 End: 03/31/17 Due: 03/31/18

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02509923 Org: User:
Start: 07/31/15 End: 09/30/16 Due: 09/30/17